An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

This study has been completed.
Sponsor:
Information provided by:
Epimmune
ClinicalTrials.gov Identifier:
NCT00054912
First received: February 12, 2003
Last updated: April 7, 2008
Last verified: April 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given